USPTO serial 79065761
TRIVERGE
Reviewed by CopyMark Law Group
Reg. 3658410Status 404
- Filing date
- Status date
- Registration date
- Jul 21, 2009
- Examiner
- MADDEN, ANNE
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TRIVERGE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidermia, anemia, blood disorders, diabetes, thyroid function disease, metabolic disorders, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation and inflammatory disease, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease; diagnostic reagents and contrast media for medical use | SECTION 18 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks owned by DAIICHI SANKYO COMPANY, LIMITED
- Other trademarks in Class 005
- Similar marks named TRIVERGE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 9, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Aug 9, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 25, 2016 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 10, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 7, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 16, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 1, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 1, 2015 | INPC | INVALIDATION PROCESSED | — |
| Sep 16, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 16, 2015 | C18. | CANCELLED SECTION 18-TOTAL | — |
| Jan 16, 2015 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Jan 7, 2015 | CANG | CANCELLATION GRANTED NO. 999999 | — |
| Sep 18, 2014 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Jul 21, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 5, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 27, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 27, 2009 | ALIE | ASSIGNED TO LIE | — |
| Mar 27, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 24, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 20, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 19, 2009 | LIMS | LIMITATION OF GOODS/SERVICES FROM IB ENTERED | — |
| Mar 19, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |